Bevacizumab for Symptomatic Vestibular Schwannoma in Neurofibromatosis Type 2 (NF2)
about
Bevacizumab for Symptomatic Vestibular Schwannoma in Neurofibromatosis Type 2 (NF2)
description
clinical trial
@en
klinisch onderzoek
@nl
name
Bevacizumab for Symptomatic Vestibular Schwannoma in Neurofibromatosis Type 2 (NF2)
@en
type
label
Bevacizumab for Symptomatic Vestibular Schwannoma in Neurofibromatosis Type 2 (NF2)
@en
prefLabel
Bevacizumab for Symptomatic Vestibular Schwannoma in Neurofibromatosis Type 2 (NF2)
@en
P1476
Phase 2 Study of Bevacizumab i ...... ptomatic Vestibular Schwannoma
@en
P3098
NCT01207687
P580
2010-10-01T00:00:00Z
P582
2013-02-01T00:00:00Z